Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside [Yahoo! Finance]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Yahoo! Finance
TheFly reported on January 7 that TD Cowen raised its price target on ILMN to $140 from $115 while maintaining a Hold rating. The change was included in the company's outlook for the life science tools industry for the fourth quarter. Although several firms have already released cautious advice for 2026, the analyst pointed out that recent share price advances have elevated expectations. TD Cowen feels this leaves space for upside next year. Separately, on January 6, Illumina Inc. (NASDAQ:ILMN) launched Illumina Connected Multiomics, a cloud-based platform designed to integrate and analyze large multiomic datasets. Illumina Inc. (NASDAQ:ILMN) develops advanced genomic sequencing and multiomics solutions, enabling precision oncology research, biomarker discovery, and targeted therapies. Its AI-driven platforms accelerate cancer diagnostics, drug development, and personalized treatment strategies, positioning the company as a leader in oncology-focused genomic innovation. While w
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Illumina secures CMS reimbursement for TruSightâ„¢ Oncology Comprehensive, expanding access to precision oncologyPR Newswire
- Illumina (NASDAQ:ILMN) was given a new $155.00 price target on by analysts at Stifel Nicolaus.MarketBeat
- Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery [Yahoo! Finance]Yahoo! Finance
- Illumina introduces Billion Cell Atlas to accelerate AI and drug discoveryPR Newswire
- Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025PR Newswire
ILMN
Earnings
- 10/30/25 - Beat
ILMN
Sec Filings
- 1/13/26 - Form 8-K
- 1/8/26 - Form 8-K
- 1/5/26 - Form 4
- ILMN's page on the SEC website